INIS
children
100%
patients
38%
obesity
30%
diseases
28%
risks
27%
symptoms
21%
interventions
21%
weight
18%
inflammation
17%
adolescents
16%
infants
15%
fibrosis
15%
lungs
14%
covid-19
14%
concentration
13%
growth
13%
humans
13%
pediatrics
12%
comparative evaluations
12%
assessments
10%
birth
10%
liver
10%
netherlands
9%
data
9%
therapy
9%
injuries
8%
kidneys
8%
quality of life
8%
insulin
8%
chickens
7%
motors
7%
adenosine
7%
genetics
7%
phenotype
7%
losses
7%
proteins
7%
lambs
7%
management
7%
sheep
7%
levels
7%
pathology
7%
blood pressure
7%
control
7%
detection
6%
monitoring
6%
diet
6%
feeding
6%
hospitals
6%
hydroxylase
5%
tyrosine
5%
mutations
5%
neonates
5%
glucose
5%
breath
5%
embryos
5%
teaching
5%
gain
5%
fetuses
5%
genotype
5%
defects
5%
surveys
5%
receptors
5%
Keyphrases
Lifestyle Intervention
18%
Dutch
14%
Cystic Fibrosis
13%
Morbid Obesity
13%
Obesity
13%
Overweight or Obesity
12%
Pulmonary Exacerbation
11%
Netherlands
10%
Risk Factors
8%
DADA2
7%
Motor Development
7%
Health-related Quality of Life
7%
Ductus Arteriosus
7%
Children with Obesity
7%
Necrotizing Enterocolitis
7%
Chorioamnionitis
7%
COVID-19 Pandemic
6%
Early Detection
6%
Pediatricians
6%
COVID-19
6%
Parechovirus
5%
Ureaplasma Infection
5%
Ureaplasma Parvum
5%
Ventricular Pacing
5%
Insulin Resistance
5%
IVF-ICSI
5%
Lung Function
5%
Respiratory Symptoms
5%
Medicine and Dentistry
Obesity
20%
Symptom
14%
Adolescent
13%
COVID-19
13%
Lifestyle Intervention
12%
Cystic Fibrosis
11%
Morbid Obesity
9%
Motor Development
7%
Physical Activity
7%
Disease
7%
Intracytoplasmic Sperm Injection
6%
Infection
6%
Pediatrician
6%
Body Mass Index
6%
Endothelial Function
6%
Insulin Resistance
6%
Randomized Controlled Trial
5%
Ureaplasma Infection
5%
Chorioamnionitis
5%
Pediatrics
5%
Necrotizing Enterocolitis
5%